Related references
Note: Only part of the references are listed.Contribution of MINCLE-SYK Signaling to Activation of Primary Human APCs by Mycobacterial Cord Factor and the Novel Adjuvant TDB
Jenny Ostrop et al.
JOURNAL OF IMMUNOLOGY (2015)
Protection Against Chlamydia trachomatis Infection and Upper Genital Tract Pathological Changes by Vaccine-Promoted Neutralizing Antibodies Directed to the VD4 of the Major Outer Membrane Protein
Anja W. Olsen et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Dissecting the Immune Response to MF59-adjuvanted and Nonadjuvanted Seasonal Influenza Vaccines in Children Less Than Three Years of Age
Luisanna Zedda et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2015)
Immune Subdominant Antigens as Vaccine Candidates against Mycobacterium tuberculosis
Mark T. Orr et al.
JOURNAL OF IMMUNOLOGY (2014)
Central Memory CD4+ T Cells Are Responsible for the Recombinant Bacillus Calmette-Gu,rin ΔureC::hly Vaccine's Superior Protection Against Tuberculosis
Alexis Vogelzang et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Interleukin-22 Promotes T Helper 1 (Th1)/Th17 Immunity in Chlamydial Lung Infection
Ying Peng et al.
MOLECULAR MEDICINE (2014)
Inducing Dose Sparing with Inactivated Polio Virus Formulated in Adjuvant CAF01
Jes Dietrich et al.
PLOS ONE (2014)
Vaccines, new opportunities for a new society
Rino Rappuoli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human
Jaap T. van Dissel et al.
VACCINE (2014)
Control of Chronic Mycobacterium tuberculosis Infection by CD4 KLRG1- IL-2-Secreting Central Memory Cells
Thomas Lindenstrom et al.
JOURNAL OF IMMUNOLOGY (2013)
Cellular immune correlates of protection against symptomatic pandemic influenza
Saranya Sridhar et al.
NATURE MEDICINE (2013)
Key roles of adjuvants in modern vaccines
Steven G. Reed et al.
NATURE MEDICINE (2013)
Immunization with a MOMP-Based Vaccine Protects Mice against a Pulmonary Chlamydia Challenge and Identifies a Disconnection between Infection and Pathology
Connor P. O'Meara et al.
PLOS ONE (2013)
ESAT-6 (EsxA) and TB10.4 (EsxH) Based Vaccines for Pre-and Post-Exposure Tuberculosis Vaccination
Truc Hoang et al.
PLOS ONE (2013)
Adjuvants and Immunization Strategies to Induce Influenza Virus Hemagglutinin Stalk Antibodies
Peter H. Goff et al.
PLOS ONE (2013)
HIV-infected patients show impaired cellular immune response to influenza vaccination compared to healthy subjects
Massimiliano Fabbiani et al.
VACCINE (2013)
The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect
Samuele Calabro et al.
VACCINE (2013)
Evaluation of safety and immunogenicity of recombinant influenza hemagglutinin (H5/Indonesia/05/2005) formulated with and without a stable oil-in-water emulsion containing glucopyranosyl-lipid A (SE plus GLA) adjuvant
John J. Treanor et al.
VACCINE (2013)
Rapidly produced SAM® vaccine against H7N9 influenza is immunogenic in mice
Armin Hekele et al.
EMERGING MICROBES & INFECTIONS (2013)
Immunosenescence and novel vaccination strategies for the elderly
Michael G. Dorrington et al.
FRONTIERS IN IMMUNOLOGY (2013)
Vaccine-Induced Th17 Cells Are Maintained Long-Term Postvaccination as a Distinct and Phenotypically Stable Memory Subset
Thomas Lindenstrom et al.
INFECTION AND IMMUNITY (2012)
A cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analog
Dennis Christensen et al.
JOURNAL OF CONTROLLED RELEASE (2012)
MF59 and Pam3CSK4 Boost Adaptive Responses to Influenza Subunit Vaccine through an IFN Type I-Independent Mechanism of Action
Elena Caproni et al.
JOURNAL OF IMMUNOLOGY (2012)
Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans
Tom M. Wilkinson et al.
NATURE MEDICINE (2012)
Adjuvant solution for pandemic influenza vaccine production
Christopher H. Clegg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The mechanism of action of MF59 - An innately attractive adjuvant formulation
D. T. O'Hagan et al.
VACCINE (2012)
Immunogenicity of Leishmania donovani iron superoxide dismutase B1 and peroxidoxin 4 in BALB/c mice: The contribution of Toll-like receptor agonists as adjuvant
Nada S. Daifalla et al.
EXPERIMENTAL PARASITOLOGY (2011)
MF59 adjuvant: the best insurance against influenza strain diversity
Derek T. O'Hagan et al.
EXPERT REVIEW OF VACCINES (2011)
Functional Capacity of Mycobacterium tuberculosis-Specific T Cell Responses in Humans Is Associated with Mycobacterial Load
Cheryl L. Day et al.
JOURNAL OF IMMUNOLOGY (2011)
A Novel Human IgA Monoclonal Antibody Protects against Tuberculosis
Sucharitha Balu et al.
JOURNAL OF IMMUNOLOGY (2011)
Influenza Hemagglutination-Inhibition Antibody Titer as a Correlate of Vaccine-Induced Protection
Suzanne E. Ohmit et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Oil-in-Water Emulsion Adjuvant with Influenza Vaccine in Young Children
Timo Vesikari et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
CAF01 Potentiates Immune Responses and Efficacy of an Inactivated Influenza Vaccine in Ferrets
Cyril Jean-Marie Martel et al.
PLOS ONE (2011)
Protection of mice from Mycobacterium tuberculosis by ID87/GLA-SE, a novel tuberculosis subunit vaccine candidate
Hillarie Plessner Windish et al.
VACCINE (2011)
Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung
Paul S. Redford et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
MF59™ as a vaccine adjuvant: a review of safety and immunogenicity
Hana El Sahly
EXPERT REVIEW OF VACCINES (2010)
Chlamydia muridarum T-Cell Antigens Formulated with the Adjuvant DDA/TDB Induce Immunity against Infection That Correlates with a High Frequency of Gamma Interferon (IFN-γ)/Tumor Necrosis Factor Alpha and IFN-γ/Interleukin-17 Double-Positive CD4+ T Cells
Hong Yu et al.
INFECTION AND IMMUNITY (2010)
Cutting Edge: Mincle Is Essential for Recognition and Adjuvanticity of the Mycobacterial Cord Factor and its Synthetic Analog Trehalose-Dibehenate
Hanne Schoenen et al.
JOURNAL OF IMMUNOLOGY (2010)
A Synthetic Adjuvant to Enhance and Expand Immune Responses to Influenza Vaccines
Rhea N. Coler et al.
PLOS ONE (2010)
Vaccines with MF59 Adjuvant Expand the Antibody Repertoire to Target Protective Sites of Pandemic Avian H5N1 Influenza Virus
Surender Khurana et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naive human volunteers
Jaap T. van Dissel et al.
VACCINE (2010)
Vaccine adjuvants: scientific challenges and strategic initiatives
Ali M. Harandi et al.
EXPERT REVIEW OF VACCINES (2009)
Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRγ-Syk-Card9-dependent innate immune activation
Kerstin Werninghaus et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Tuberculosis Subunit Vaccination Provides Long-Term Protective Immunity Characterized by Multifunctional CD4 Memory T Cells
Thomas Lindenstrom et al.
JOURNAL OF IMMUNOLOGY (2009)
Protection and Polyfunctional T Cells Induced by Ag85B-TB10.4/IC31® against Mycobacterium tuberculosis Is Highly Dependent on the Antigen Dose
Claus Aagaard et al.
PLOS ONE (2009)
Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine
Grazia Galli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels
Grazia Galli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Towards an understanding of the adjuvant action of aluminium
Philippa Marrack et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Whole inactivated virus influenza vaccine is superior to subunit vaccine in inducing immune responses and secretion of proinflammatory cytokines by DCs
Felix Geeraedts et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2008)
Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults
David I. Bernstein et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Antigenic profiling of a Chlamydia trachomatis gene-expression library
Frank Follmann et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Cationic Liposomes Formulated with Synthetic Mycobacterial Cordfactor (CAF01): A Versatile Adjuvant for Vaccines with Different Immunological Requirements
Else Marie Agger et al.
PLOS ONE (2008)
The novel adjuvant IC31® strongly improves influenza vaccine-specific cellular and humoral immune responses in young adult and aged mice
Karin Riedl et al.
VACCINE (2008)
Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies
Carmen Giefing et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
T-cell quality in memory and protection: implications for vaccine design
Robert A. Seder et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Protective immunity to tuberculosis with Ag85B-ESAT-6 in a synthetic cationic adjuvant system IC31
Else Marie Agger et al.
VACCINE (2006)
IC31, a novel adjuvant signaling via TLR9, induces potent cellular and humoral immune responses
Carola Schellack et al.
VACCINE (2006)
Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6′-dibehenate) -: A novel adjuvant inducing both strong CMI and antibody responses
J Davidsen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2005)
Identification of lectin-like receptors expressed by antigen presenting cells and neutrophils and their mapping to a novel gene complex
LM Flornes et al.
IMMUNOGENETICS (2004)
Vaccine adjuvants: Current state and future trends
N Petrovsky et al.
IMMUNOLOGY AND CELL BIOLOGY (2004)
A Chlamydia trachomatis-specific Th2 clone does not provide protection against a genital infection and displays reduced trafficking to the infected genital mucosa
RA Hawkins et al.
INFECTION AND IMMUNITY (2002)
Share Paper
